Acetate-mediated growth inhibition in sterol 14α-demethylation- deficient cells of Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 100-105

  Shimokawa, Osamu ^a   Nakayama, Hiroaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTIFUNGAL AGENT; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; SODIUM CHLORIDE; STEROL;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; DRUG MECHANISM; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0032906804     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.100     Document Type: Article

References (16)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Bard, M., N. D. Lees, R. J. Barbuch, and D. Sanglard. 1987. Characterization of a cytochrome P450 deficient mutant of Candida albicans. Biochem. Biophys. Res. Commun. 147:794-800.
3. Bard, M., N. D. Lees, T. Turi, D. Craft, L. Cofrin, R. Barbuch, C. Koegel, and J. C. Loper. 1993. Sterol synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans. Lipids 28:963-967.
4. Bryson, V., and W. Szybalski. 1952. Microbial selection. Science 116:45-51.
5. DeBrabander, M., F. Aerts, J. Van Cutsem, H. Vanden Bossche, and M. Borgers. 1980. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia 18:197-210.
6. Lees, N. D., M. C. Broughton, D. Sanglard, and M. Bard. 1990 Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans. Antimicrob. Agents Chemother. 34:831-836.
7. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeast. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. Nishikawa, T., S. Tokunaga, H. Fuse, M. Takashima, T. Noda, M. Ohkawa, S. Nakamura, and M. Namiki. 1997. Experimental study of ascending Candida albicans pyelonephritis focusing on the hyphal form and oxidant injury. Urol. Int. 58:131-136.
9. Odds, F. C. 1992. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. Antimicrob. Agents Chemother. 36:1727-1737.
10. Pierce, A. M., H. D. Pierce, A. M. Unrau, and A. C. Oehlschlager. 1978. Lipid composition and polyene antibiotic resistance of Candida albicans mutants. Can. J. Biochem. 56:135-142.
11. Shigematsu, M. L., J. Uno, and T. Arai. 1981. Correlative studies on in vivo and in vitro effectiveness of ketoconazole against Candida albicans infection. Jpn. J. Med. Mycol. 22:195-201.
12. Shimokawa, O., Y. Kato, and H. Nakayama. 1986. Accumulation of 14-methyl sterols and defective hyphal growth in Candida albicans. J. Med. Vet. Mycol. 24:327-336.
13. Shimokawa, O., Y. Kato, and H. Nakayama. 1986. Increased drug sensitivity in Candida albicans cells accumulating 14-methylated sterols. J. Med. Vet. Mycol. 24:481-483.
14. Shimokawa, O., Y. Kato, K. Kawano, and H. Nakayama. 1989. Accumulation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol in 14α-demethylation mutant of Candida albicans: genetic evidence for the involvement of 5-desaturase. Biochim. Biophys. Acta 1003:15-19.
15. Shimokawa, O., and H. Nakayama. 1992. Increased sensitivity of Candida albicans cells accumulating 14α-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents. Antimicrob. Agents Chemother. 36:1626-1629.
16. Vanden Bossche, H., G. Willemsens, W. Cools, W. F. G. Lauwers, and L. Le Jeune. 1978. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem.-Biol. Interact. 21:59-78.